BridgeBio Pharma reports inducement RSU grants for 63,009 shares to 36 new hires

• BridgeBio Pharma granted restricted stock units covering 63,009 common shares to 36 new employees on Sept. 18, 2026.
• Vesting starts Nov. 16, 2027, with 25% vesting then.
• The remaining 75% vests quarterly in equal installments, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609181601PRIMZONEFULLFEED9829754) on September 18, 2026, and is solely responsible for the information contained therein.